TARS NASDAQ
Tarsus Pharmaceuticals, Inc.
1W: -3.5%
1M: -11.8%
3M: +8.9%
YTD: -9.6%
1Y: +27.3%
3Y: +362.3%
5Y: +220.5%
$73.00
-2.46 (-3.26%)
Weekly Expected Move ±7.1%
$63
$68
$73
$78
$83
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2021-03-30
Earliest Filing
2021-03-30
Latest Filing
partner: 1
Counterparties (Filed by TARS)
1 relationshipsCompanies named in TARS's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-10 | Acquisition/Disposition; Other Events; Exhibits | Acquisition | View |
| 2026-08-06 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-08-06 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-07-13 | Officer/Director Change | View | |
| 2026-07-08 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-06-29 | Shareholder Vote | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-02-23 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-18 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-18 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-18 | Other Events | View | |
| 2025-03-13 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-17 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR